Can gene therapies for haemophilia defend their high price tags?
Pharmaceutical Technology
NOVEMBER 9, 2022
Known by the brand name Roctavian, BioMarin’s haemophilia A therapy valoctocogene roxaparvovec could be fairly priced in the range of $1.95–1.96 BioMarin’s Roctavian has a target PDUFA action date of March 31 next year. million price tag. million, the think tank concluded in its updated evaluation. million ($1.5
Let's personalize your content